MJardin Group Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on MJardin Group's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2021

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How MJardin Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:MJAR.F Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 216-56100
30 Jun 2110-27150
31 Mar 2111-27160
31 Dec 2011-30190
30 Sep 2011-240270
30 Jun 2013-260270
31 Mar 2018-257340
31 Dec 1927-265440
30 Sep 1931-108620
30 Jun 1933-96590
31 Mar 1931-95550
31 Dec 1828-81430
30 Sep 1826-8280
30 Jun 1822-6260
31 Mar 1822-1200
31 Dec 17202180
31 Dec 1616-120
31 Dec 154-320

Quality Earnings: Insufficient data to determine if MJAR.F has high quality earnings.

Growing Profit Margin: Insufficient data to determine if MJAR.F's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if MJAR.F's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare MJAR.F's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if MJAR.F's earnings growth over the past year exceeded the Pharmaceuticals industry average.


Return on Equity

High ROE: MJAR.F has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 03:01
End of Day Share Price 2024/12/31 00:00
Earnings2021/09/30
Annual Earnings2020/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MJardin Group, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert BurlesonCanaccord Genuity